发明名称 Heparin-derived oligosaccharide mixtures, preparation thereof and pharmaceutical compositions containing said mixtures
摘要 Mixture (A) of oligosaccharides (OS) that have the general structure of polysaccharides that make up heparin, with mean molecular weight 1.8-2.4 kD; anti-Xa activity of 190-450 international units (IU)/mg and (practically) no anti-IIa activity, are new. Mixture (A) of oligosaccharides (OS) that have the general structure of polysaccharides that make up heparin,with mean molecular weight 1.8-2.4 kD; anti-Xa activity 190-450 international units (IU)/mg and (practically) no anti-IIa activity. The OS contain 2-16 sugar residues; have a 4,5-unsaturated uronic acid-2-O-sulfate residue at one end and contain the hexasaccharides (X), as alkali or alkaline earth metal salt. [Image] An independent claim is also included for a method for preparing (A). ACTIVITY : Anticoagulant; Thrombolytic; Antianginal; Cardiant; Vasotropic; Antiarteriosclerotic; Cytostatic; Antidiabetic; Ophthalomological; Nephrotropic. MECHANISM OF ACTION : Inhibition of activated factor X. The hexasaccharide (X) has strong affinity for antithrombin III and anti-Xa activity over 740 IU/mg.
申请公布号 AU2004259111(B2) 申请公布日期 2009.06.11
申请号 AU20040259111 申请日期 2004.07.22
申请人 AVENTIS PHARMA S.A. 发明人 PIERRE MOURIER;VOLKER LAUX;CHRISTIAN VISKOV
分类号 A61K31/727;A61P7/02;C08B37/00 主分类号 A61K31/727
代理机构 代理人
主权项
地址